Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: A 3-month placebo-controlled clinical trial in patients with type 2 diabetes and healthy controls. [electronic resource]
Producer: 20181211Description: 1435-1444 p. digitalISSN:- 1463-1326
- Aged
- Blood Glucose -- metabolism
- Body Composition -- physiology
- Diabetes Mellitus, Type 2 -- blood
- Drug Administration Schedule
- Fatty Acids, Nonesterified -- metabolism
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin -- metabolism
- Lipoproteins, VLDL -- metabolism
- Liver -- metabolism
- Male
- Metformin -- administration & dosage
- Middle Aged
- Oxidation-Reduction -- drug effects
- Positron-Emission Tomography
- Triglycerides -- metabolism
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.